SMTL ID : 2z2c.1

MURA inhibited by unag-cnicin adduct

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 2.05 Å

Oligo State

homo-tetramer

Ligands

4 x UDP: URIDINE-5'-DIPHOSPHATE(Non-covalent)

UDP.1: 13 residues within 4Å: Chain A: R.120, P.121, V.122, D.123, L.124, H.125, K.160, S.162, V.163, G.164, V.327, F.328 Ligands: UDC.2 17 PLIP interactions: 17 interactions with chain A Hydrophobic interactions: A:L.124 Hydrogen bonds: A:R.120, A:D.123, A:L.124, A:H.125, A:S.162, A:V.163, A:G.164 Water bridges: A:R.120, A:R.120, A:K.160, A:K.160, A:K.160, A:V.327, A:E.329, A:E.329 Salt bridges: A:R.120 UDP.3: 14 residues within 4Å: Chain B: R.120, P.121, V.122, D.123, L.124, H.125, K.160, V.161, S.162, V.163, G.164, V.327, F.328 Ligands: UDC.4 11 PLIP interactions: 11 interactions with chain B Hydrogen bonds: B:R.120, B:D.123, B:L.124, B:H.125, B:S.162, B:V.163, B:G.164 Water bridges: B:R.120, B:R.120, B:E.329 Salt bridges: B:R.120 UDP.5: 14 residues within 4Å: Chain C: R.120, P.121, V.122, D.123, L.124, H.125, K.160, V.161, S.162, V.163, G.164, V.327, F.328 Ligands: UDC.6 13 PLIP interactions: 13 interactions with chain C Hydrogen bonds: C:R.120, C:D.123, C:L.124, C:H.125, C:S.162, C:V.163, C:G.164 Water bridges: C:R.120, C:R.120, C:K.160, C:K.160, C:E.329 Salt bridges: C:R.120 UDP.7: 14 residues within 4Å: Chain D: R.120, P.121, V.122, D.123, L.124, H.125, K.160, V.161, S.162, V.163, G.164, V.327, F.328 Ligands: UDC.8 11 PLIP interactions: 11 interactions with chain D Hydrogen bonds: D:R.120, D:D.123, D:L.124, D:H.125, D:S.162, D:V.163, D:G.164 Water bridges: D:R.120, D:R.120, D:E.329 Salt bridges: D:R.120

4 x UDC: 2-acetamido-3-O-[(2S,3S)-2-carboxy-3,4-dihydroxybutan-2-yl]-2-deoxy-alpha-D-glucopyranose(Non-covalent)(Post Translational Modification)

UDC.2: 12 residues within 4Å: Chain A: K.22, N.23, W.95, R.120, V.163, T.304, D.305, F.328, R.331, L.370, R.371 Ligands: UDP.1 21 PLIP interactions: 21 interactions with chain A Hydrophobic interactions: A:W.95 Hydrogen bonds: A:K.22, A:N.23, A:N.23, A:R.120, A:R.120, A:D.305, A:R.331 Water bridges: A:E.188, A:E.188, A:R.232, A:H.299, A:T.304, A:T.304, A:T.304, A:L.370, A:R.371, A:R.397 Salt bridges: A:K.22, A:R.331, A:R.371 UDC.4: 13 residues within 4Å: Chain B: K.22, N.23, A.92, W.95, R.120, V.163, T.304, D.305, F.328, R.331, L.370, R.371 Ligands: UDP.3 23 PLIP interactions: 23 interactions with chain B Hydrophobic interactions: B:A.92, B:W.95 Hydrogen bonds: B:K.22, B:K.22, B:N.23, B:N.23, B:R.120, B:R.120, B:D.305, B:R.331 Water bridges: B:E.188, B:E.188, B:R.232, B:R.232, B:T.304, B:T.304, B:T.304, B:L.370, B:R.371, B:R.397 Salt bridges: B:K.22, B:R.331, B:R.371 UDC.6: 14 residues within 4Å: Chain C: K.22, N.23, L.26, W.95, R.120, V.163, T.304, D.305, F.328, R.331, L.370, R.371, R.397 Ligands: UDP.5 24 PLIP interactions: 24 interactions with chain C Hydrophobic interactions: C:L.26, C:W.95 Hydrogen bonds: C:K.22, C:K.22, C:N.23, C:N.23, C:R.120, C:R.120, C:R.120, C:E.188, C:D.305, C:R.331, C:R.397 Water bridges: C:R.232, C:H.299, C:T.304, C:T.304, C:T.304, C:R.331, C:L.370, C:R.397 Salt bridges: C:K.22, C:R.331, C:R.371 UDC.8: 15 residues within 4Å: Chain D: K.22, N.23, A.92, W.95, I.117, R.120, V.163, T.304, D.305, F.328, R.331, L.370, R.371, R.397 Ligands: UDP.7 26 PLIP interactions: 26 interactions with chain D Hydrophobic interactions: D:A.92, D:W.95, D:I.117 Hydrogen bonds: D:K.22, D:N.23, D:N.23, D:N.23, D:D.305, D:R.331, D:R.397 Water bridges: D:R.120, D:R.120, D:E.188, D:E.188, D:R.232, D:R.232, D:T.304, D:T.304, D:T.304, D:L.370, D:L.370, D:L.370, D:R.397 Salt bridges: D:K.22, D:R.331, D:R.371

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Steinbach, A. et al., The Antibacterial Target Enzyme Mura Synthesizes its Own Non-Covalent Suicide Inhibitor from the Natural Product Cnicin. To be Published

Release Date

2008-05-20

Peptides

UDP-N-acetylglucosamine 1-carboxyvinyltransferase: ABCD

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

C
C

D
D

UDP-N-acetylglucosamine 1-carboxyvinyltransferase